These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 21987594)

  • 1. Strategies, development, and pitfalls of therapeutic options for Alzheimer's disease.
    Haas C
    J Alzheimers Dis; 2012; 28(2):241-81. PubMed ID: 21987594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological treatment for Alzheimer's disease: current approaches and future strategies.
    Fan LY; Chiu MJ
    Acta Neurol Taiwan; 2010 Dec; 19(4):228-45. PubMed ID: 21213151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease: cholesterol a menace?
    Mathew A; Yoshida Y; Maekawa T; Kumar DS
    Brain Res Bull; 2011 Aug; 86(1-2):1-12. PubMed ID: 21741455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel disease-modifying therapies for Alzheimer's disease.
    Jiang T; Yu JT; Tan L
    J Alzheimers Dis; 2012; 31(3):475-92. PubMed ID: 22669013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards development of drugs targeting both amyloid and tau pathologies of Alzheimer's disease.
    Shin J
    Int J Geriatr Psychiatry; 2011 May; 26(5):546-8. PubMed ID: 21446001
    [No Abstract]   [Full Text] [Related]  

  • 6. Amyloid clearance as a treatment target against Alzheimer's disease.
    Kurz A; Perneczky R
    J Alzheimers Dis; 2011; 24 Suppl 2():61-73. PubMed ID: 21422524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library.
    Larbanoix L; Burtea C; Ansciaux E; Laurent S; Mahieu I; Vander Elst L; Muller RN
    Peptides; 2011 Jun; 32(6):1232-43. PubMed ID: 21575663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's disease amyloid hypothesis at crossroads: where do we go from here?
    Saxena U
    Expert Opin Ther Targets; 2010 Dec; 14(12):1273-7. PubMed ID: 21058918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond amyloid: the future of therapeutics for Alzheimer's disease.
    Lane RF; Shineman DW; Steele JW; Lee LB; Fillit HM
    Adv Pharmacol; 2012; 64():213-71. PubMed ID: 22840749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in the therapy of Alzheimer's disease: targeting amyloid beta and tau and perspectives for the future.
    Hampel H; Schneider LS; Giacobini E; Kivipelto M; Sindi S; Dubois B; Broich K; Nisticò R; Aisen PS; Lista S
    Expert Rev Neurother; 2015 Jan; 15(1):83-105. PubMed ID: 25537424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel insights for the treatment of Alzheimer's disease.
    Kurz A; Perneczky R
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):373-9. PubMed ID: 20655969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Calcium hypothesis of Alzheimer disease].
    Riazantseva MA; Mozhaeva GN; Kaznacheeva EV
    Usp Fiziol Nauk; 2012; 43(4):59-72. PubMed ID: 23227722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetically augmenting tau levels does not modulate the onset or progression of Abeta pathology in transgenic mice.
    Oddo S; Caccamo A; Cheng D; Jouleh B; Torp R; LaFerla FM
    J Neurochem; 2007 Aug; 102(4):1053-63. PubMed ID: 17472708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concerted changes in transcripts in the prefrontal cortex precede neuropathology in Alzheimer's disease.
    Bossers K; Wirz KT; Meerhoff GF; Essing AH; van Dongen JW; Houba P; Kruse CG; Verhaagen J; Swaab DF
    Brain; 2010 Dec; 133(Pt 12):3699-723. PubMed ID: 20889584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic potential of oxidant mechanisms in Alzheimer's disease.
    Moreira PI; Smith MA; Zhu X; Santos MS; Oliveira CR; Perry G
    Expert Rev Neurother; 2004 Nov; 4(6):995-1004. PubMed ID: 15853526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cholinergic system in aging and neuronal degeneration.
    Schliebs R; Arendt T
    Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's disease-related lesions.
    Alafuzoff I
    J Alzheimers Dis; 2013; 33 Suppl 1():S173-9. PubMed ID: 22695621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The amyloid cascade hypothesis has misled the pharmaceutical industry.
    Biochem Soc Trans; 2011 Aug; 39(4):920-3. PubMed ID: 21787324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventive and therapeutic types of environmental enrichment counteract beta amyloid pathology by different molecular mechanisms.
    Herring A; Lewejohann L; Panzer AL; Donath A; Kröll O; Sachser N; Paulus W; Keyvani K
    Neurobiol Dis; 2011 Jun; 42(3):530-8. PubMed ID: 21406231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.